IP Library Granted Patent US 8,470,572
Granted Patent B2
US 8,470,572 · App. 13/569,900 · Granted Jun 25, 2013

Ketoreductase polypeptides for the production of azetidinone

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,470,572
App. No.
13/569,900
Granted
Jun 25, 2013
Kind
B2
Abstract

The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize a variety of chiral compounds.

Claims (11)

1. An isolated or recombinant polynucleotide encoding an engineered ketoreductase polypeptide which comprises an amino acid sequence that is

(a) at least 90% identical to SEQ ID NO: 4 and in which the residue corresponding to X94 is threonine, the residue corresponding to X199 is alanine, histidine, or asparagine; and the residue corresponding to X202 is valine or leucine; or

(b) at least 90% identical to SEQ ID NO: 66 and which comprises a set of mutations as compared to SEQ ID NO: 4 of any one of the polypeptide sequences of SEQ ID NO: 64, 66, 68, 70, 72, 74, 76, 78, 80, or 82.

2. The polynucleotide of claim 1 , which is a sequence corresponding to SEQ ID NO: 5, 7, 9, 11, 19, 21, 23, 29, 31, 33, 35, 37, 63, 65, 67, 69, 71, 73, 75, 77, 79, or 81.

3. An expression vector comprising the polynucleotide of claim 1 operably linked to control sequences suitable for directing expression in a host cell.

4. The expression vector of claim 3 , wherein the control sequence comprises a promoter.

5. The expression vector of claim 4 , wherein the promoter comprises an E. coli promoter.

6. The expression vector of claim 4 , wherein the control sequence comprises a secretion signal.

7. A bacterial or fungal host cell comprising the expression vector of claim 3 .

8. The host cell of claim 7 , which is E. coli.

9. A method for preparing an engineered ketoreductase polypeptide comprising expressing a polynucleotide of claim 1 in a bacterial or fungal host cell and recovering the polypeptide from the host cell or culture medium.

Assignments (1)
SECURITY INTEREST Recorded Feb 15, 2024
From: CODEXIS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 066600/0650 →